Journal article
Consensus Recommendations for Studies of Outflow Facility and Intraocular Pressure Regulation Using Ex Vivo Perfusion Approaches
Investigative ophthalmology & visual science, Vol.65(14), 32
12/02/2024
DOI: 10.1167/iovs.65.14.32
PMCID: PMC11708870
PMID: 39693082
Abstract
Intraocular pressure (IOP) elevation is the primary risk factor and currently the main treatable factor for progression of glaucomatous optic neuropathy. In addition to direct clinical and living animal in vivo studies, ex vivo perfusion of anterior segments and whole eyes is a key technique for studying conventional outflow function as it is responsible for IOP regulation. We present well-tested experimental details, protocols, considerations, advantages, and limitations of several ex vivo model systems for studying IOP regulation. These include: (1) perfused whole globes, (2) stationary anterior segment organ culture, (3) perfused human anterior segment organ culture, (4) perfused animal anterior segment organ culture, (5) perfused human corneal rims, and (6) perfused human anterior segment wedges. These methods, with due consideration paid to their strengths and limitations, comprise a set of very strong tools for extending our understanding of IOP regulation.
Details
- Title: Subtitle
- Consensus Recommendations for Studies of Outflow Facility and Intraocular Pressure Regulation Using Ex Vivo Perfusion Approaches
- Creators
- Ted S Acott - Oregon Health & Science UniversityMichael P Fautsch - Mayo ClinicWeiming Mao - Indiana University School of MedicineC Ross Ethier - The Wallace H. Coulter Department of Biomedical EngineeringAlex S Huang - University of California San DiegoMary J Kelley - Oregon Health & Science UniversityMini Aga - Oregon Health & Science UniversitySanjoy K Bhattacharya - University of MiamiTerete Borras - University of North Carolina at Chapel HillDiane Bovenkamp - BrightFocus FoundationUttio Roy Chowdhury - Mayo ClinicAbbot F Clark - University of North Texas Health Science CenterMohammed I Dibas - AbbVieYiqin Du - University of South FloridaMichael H Elliott - University of Oklahoma Health Sciences CenterJennifer A Faralli - University of Wisconsin–MadisonHaiyan Gong - Boston UniversitySamuel Herberg - SUNY Upstate Medical UniversityMurray A Johnstone - University of WashingtonPaul L Kaufman - University of Wisconsin–MadisonKate E Keller - Oregon Health & Science UniversityRuth A Kelly - Duke UniversityDavid Krizaj - University of UtahMarkus H Kuehn - University of IowaHoi Lam Li - Boston UniversityRaquel Lieberman - Georgia Institute of TechnologyShan C Lin - Glaucoma Research FoundationYutao Liu - Augusta UniversityFiona S McDonnell - Eye Institute of UtahColleen M McDowell - University of Wisconsin–MadisonGillian J McLellan - University of Wisconsin–MadisonPhilip Mzyk - Duke UniversityKayarat Saidas Nair - University of California, San FranciscoDarryl R Overby - Imperial College LondonDonna M Peters - University of Wisconsin–MadisonVijayKrishna Raghunathan - Novartis Institutes for BioMedical ResearchPonugoti Vasantha Rao - Duke UniversityGavin W Roddy - Mayo ClinicNajam A Sharif - SantenMyoung Sup Shim - Duke UniversityYang Sun - Stanford UniversityBenjamin R Thomson - Northwestern UniversityCarol B Toris - The Ohio State University Wexner Medical CenterColin E Willoughby - University of UlsterHao F Zhang - Northwestern UniversityThomas F Freddo - MCPHS UniversityRudolf Fuchshofer - University of RegensburgKamisha R Hill - Georgia Institute of TechnologyAlireza Karimi - Oregon Health & Science UniversityKrishnakumar Kizhatil - The Ohio State UniversityCasey C Kopcyznski - Aerie PharmaceuticalsPaloma Liton - Duke UniversityGaurang Patel - University of North Texas Health Science CenterMichael Peng - Indiana University School of MedicinePadmanabhan P Pattabiraman - Indiana University School of MedicineGanesh Prasanna - NovartisEster Reina-Torres - Imperial College LondonE Griffen Samples - Glaucoma FoundationJohn R Samples - Washington State University SpokaneCynthia L SteelClemens A Strohmaier - Johannes Kepler University of LinzPreeti Subramanian - BrightFocus FoundationChenna Kesavulu Sugali - Indiana University School of MedicineJoseph van Batenburg-Sherwood - Imperial College LondonCydney Wong - The Wallace H. Coulter Department of Biomedical EngineeringHannah Youngblood - Georgia Institute of TechnologyGulab S Zode - University of California, IrvineElizabeth White - Oregon Health & Science UniversityW Daniel Stamer - Duke University
- Resource Type
- Journal article
- Publication Details
- Investigative ophthalmology & visual science, Vol.65(14), 32
- DOI
- 10.1167/iovs.65.14.32
- PMID
- 39693082
- PMCID
- PMC11708870
- NLM abbreviation
- Invest Ophthalmol Vis Sci
- ISSN
- 1552-5783
- eISSN
- 1552-5783
- Publisher
- ASSOC RESEARCH VISION OPHTHALMOLOGY INC
- Grant note
- National Eye Institute: EY026529, EY031631, EY033961, EY023242, EY032960, EY028671, EY014800, EY027920, EY031817, EY002423, EY021205, EY026885, EY033600, EY034096, EY022634, EY025643, EY026962, EY031700, EY033929, EY036011 BrightFocus FoundationResearch to Prevent BlindnessAerie PharmaceuticalsGlaukos CorporationGlaucoma Research FoundationWestern Glaucoma FoundationLewis Rudin Glaucoma PrizeAllergan by AbbVie
Supported by grants from the National Eye Institute, National EY026529 to CMM; EY031631 to YL; EY033961 to YL; EY023242 to YL; EY032960 to YL; EY028671 to YL; EY014800 to DK; EY027920 to DK; EY031817 to DK; EY002423 to DK; EY021205 to RLL; EY026885 to PL; EY033600 to PL; EY034096 to SH; EY022634 to HG; EY025643 to YD; EY026962 to WM; EY031700 to WM; EY033929 to WM; EY036011 to AK) ; The BrightFocus Foundation; Research to Prevent Blindness; Aerie Pharmaceuticals; Glaukos Corporation; Glaucoma Research Foundation; Western Glaucoma Foundation; Lewis Rudin Glaucoma Prize to MJK) ; and Allergan by AbbVie.
- Language
- English
- Date published
- 12/02/2024
- Academic Unit
- Ophthalmology and Visual Sciences
- Record Identifier
- 9984758266202771
Metrics
2 Record Views